Ironwood Pharmaceuticals | Ativo Circulante



Current Assets Alterar Data
Acadia Pharmaceuticals USD 960.55M 89.61M 2025-06
Agios Pharmaceuticals USD 1.02B 50.85M 2025-06
Almirall EUR 714.05M 50.55M 2025-06
Alnylam Pharmaceuticals USD 3.64B 375.44M 2025-06
Amarin USD 573.06M 22.34M 2025-03
Ardelyx USD 356.45M 72.35M 2024-12
Astellas Pharma JPY 1.29T 91.98B 2025-06
AstraZeneca USD 28.94B 2.8B 2025-06
Charles River Laboratories USD 1.47B 36.5M 2025-06
Exact Sciences USD 1.51B 137.52M 2025-06
Halozyme Therapeutics USD 1.12B 139.35M 2025-06
Incyte USD 3.64B 411.91M 2025-06
Ironwood Pharmaceuticals USD 182.42M 3.81M 2024-12
MacroGenics USD 217.49M 4.71M 2024-12
Moderna USD 6.17B 595M 2025-06
Myriad Genetics USD 287.2M 10.8M 2025-03
Pacira USD 745.61M 14.35M 2025-06
PTC Therapeutics USD 2.27B 43.53M 2025-06
Sarepta Therapeutics USD 2.66B 224.45M 2025-06
Takeda JPY 2.51T 8.07B 2025-06
Ultragenyx Pharmaceutical USD 719.79M 20.63M 2025-06


Ironwood Pharmaceuticals Ativo Circulante - Valores atuais, dados históricos, previsões, estatísticas, gráficos e calendário econômico - Aug 2025.